avapro has been researched along with Interstitial Nephritis in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ren, X | 1 |
Guan, G | 1 |
Liu, G | 2 |
Liu, BC | 1 |
Xia, HL | 1 |
Wu, JN | 1 |
Zhang, XL | 1 |
Liu, DG | 1 |
Gong, YX | 1 |
2 other studies available for avapro and Interstitial Nephritis
Article | Year |
---|---|
Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats.
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Glucose; Connect | 2009 |
Influence of irbesartan on expression of ILK and its relationship with epithelial-mesenchymal transition in mice with unilateral ureteral obstruction.
Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Cadherins; Cell Transd | 2007 |